MITO logo

Stealth BioTherapeutics (MITO) EBITDA

Annual EBITDA

-$51.21 M
+$4.21 M+7.60%

December 31, 2021

Summary

Performance

1-Year Change

+7.6%

3-Year Change

+31.76%

5-Year Change

+35.41%

15-Year Change

+35.41%

MITO EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$51.21 M
MITO annual EBITDA is currently at an all-time high

3-Year Low

-$51.21 M
MITO annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
MITO previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
MITO next annual earnings announcement has not yet been scheduled

OtherMITOprofitabilitymetrics:

Annual Revenue

-
MITO annual revenue value is unknown

Annual Net Income

-$52.53 M
MITO annual net profit is -$52.53 million

Annual EBIT

-$51.28 M
MITO annual earnings before interest & taxes is -$51.28 million

Annual EPS

-$0.96
MITO annual earnings per share is -$0.96

Quarterly EBITDA

-$7.59 M
+$11.98 M+61.20%

March 31, 2022

Summary

Performance

3-Month Change

+61.2%

1-Year Change

-2.79%

3-Year Change

+80.27%

5-Year Change

+62.8%

MITO Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$4.46 M
MITO quarterly EBITDA is currently -270.18% below its historical high of $4.46 million

3-Year Low

-$19.58 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
MITO previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
MITO next earnings announcement has not yet been scheduled

OtherMITOprofitabilitymetrics:

Quarterly Revenue

-
MITO quarterly revenue value is unknown

Quarterly Net Income

-$8.14 M
MITO quarterly net profit is -$8.14 million

Quarterly EBIT

-$7.59 M
MITO quarterly earnings before interest & taxes is -$7.59 million

Quarterly EPS

-$0.12
MITO quarterly earnings per share is -$0.12

TTM EBITDA

-$51.49 M
-$206.00 K-0.40%

March 31, 2022

Summary

Performance

3-Month Change

-0.4%

1-Year Change

-7.19%

3-Year Change

+20.77%

5-Year Change

+20.77%

MITO TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$20.41 M

3-Year Low

-$51.49 M
MITO TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
MITO previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
MITO next earnings announcement has not yet been scheduled

OtherMITOprofitabilitymetrics:

TTM Revenue

-
MITO TTM revenue value is unknown

TTM Net Income

-$52.97 M
MITO TTM net profit is -$52.97 million

TTM EBIT

-$51.49 M
MITO TTM earnings before interest & taxes is -$51.49 million

TTM EPS

-$0.96
MITO TTM earnings per share is -$0.96

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$51.21 M
MITO annual EBITDA is -$51.21 million

Annual Net Income

-$52.53 M
MITO annual net profit is -$52.53 million

Annual Interest Expense

-
MITO annual interest expense value is unknown

Annual Income Tax

-
MITO annual income tax value is unknown

Annual D&A

-
MITO annual depreciation & amortization value is unknown

MITO EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.6%-2.8%-7.2%
3 y3 years+31.8%+80.3%+20.8%
5 y5 years+35.4%+62.8%+20.8%

MITO EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high+157.8%+0.4%at low
5 y5-yearat high+26.5%-270.2%+157.8%+55.2%+26.2%
alltimeall timeat high+54.8%-270.2%+406.8%+152.2%+88.0%

Stealth BioTherapeutics EBITDA History

DateAnnualQuarterlyTTM
Mar 2022
-
-$7.59 M(-61.2%)
-$51.49 M(+0.4%)
Dec 2021
-$51.21 M(-7.6%)
-$19.58 M(+220.9%)
-$51.28 M(+3.4%)
Sep 2021
-
-$6.10 M(-66.5%)
-$49.62 M(-8.7%)
Jun 2021
-
-$18.22 M(+146.6%)
-$54.34 M(+13.1%)
Mar 2021
-
-$7.39 M(-58.7%)
-$48.04 M(-13.5%)
Dec 2020
-$55.42 M(-14.5%)
-$17.91 M(+65.4%)
-$55.55 M(+67.4%)
Sep 2020
-
-$10.83 M(-9.1%)
-$33.18 M(-13.2%)
Jun 2020
-
-$11.91 M(-20.1%)
-$38.22 M(-7.7%)
Mar 2020
-
-$14.90 M(-433.9%)
-$41.40 M(-36.3%)
DateAnnualQuarterlyTTM
Dec 2019
-$64.78 M(-13.7%)
$4.46 M(-128.1%)
-$64.99 M(-27.0%)
Sep 2019
-
-$15.87 M(+5.2%)
-$89.03 M(-0.8%)
Jun 2019
-
-$15.09 M(-60.8%)
-$89.75 M(-7.3%)
Mar 2019
-
-$38.49 M(+96.6%)
-$96.81 M(+28.6%)
Dec 2018
-$75.05 M(-5.3%)
-$19.58 M(+18.1%)
-$75.28 M(-1.1%)
Sep 2018
-
-$16.59 M(-25.1%)
-$76.11 M(+27.9%)
Jun 2018
-
-$22.15 M(+30.6%)
-$59.53 M(+59.3%)
Mar 2018
-
-$16.96 M(-16.9%)
-$37.38 M(+83.1%)
Dec 2017
-$79.28 M(+30.5%)
-$20.41 M
-$20.41 M
Dec 2016
-$60.74 M
-
-

FAQ

  • What is Stealth BioTherapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Stealth BioTherapeutics?
  • What is Stealth BioTherapeutics annual EBITDA year-on-year change?
  • What is Stealth BioTherapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Stealth BioTherapeutics?
  • What is Stealth BioTherapeutics quarterly EBITDA year-on-year change?
  • What is Stealth BioTherapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Stealth BioTherapeutics?
  • What is Stealth BioTherapeutics TTM EBITDA year-on-year change?

What is Stealth BioTherapeutics annual EBITDA?

The current annual EBITDA of MITO is -$51.21 M

What is the all time high annual EBITDA for Stealth BioTherapeutics?

Stealth BioTherapeutics all-time high annual EBITDA is -$51.21 M

What is Stealth BioTherapeutics annual EBITDA year-on-year change?

Over the past year, MITO annual EBITDA has changed by +$4.21 M (+7.60%)

What is Stealth BioTherapeutics quarterly EBITDA?

The current quarterly EBITDA of MITO is -$7.59 M

What is the all time high quarterly EBITDA for Stealth BioTherapeutics?

Stealth BioTherapeutics all-time high quarterly EBITDA is $4.46 M

What is Stealth BioTherapeutics quarterly EBITDA year-on-year change?

Over the past year, MITO quarterly EBITDA has changed by -$206.00 K (-2.79%)

What is Stealth BioTherapeutics TTM EBITDA?

The current TTM EBITDA of MITO is -$51.49 M

What is the all time high TTM EBITDA for Stealth BioTherapeutics?

Stealth BioTherapeutics all-time high TTM EBITDA is -$20.41 M

What is Stealth BioTherapeutics TTM EBITDA year-on-year change?

Over the past year, MITO TTM EBITDA has changed by -$3.45 M (-7.19%)